Larvol Delta - Evaluating-Safety-Tolerability-and-Potential-Efficacy-of-Intranasal-AD17002-in-Adults-With-Mild-COVID19

AD17002 - Advagene Biopharma

http://clinicaltrials.gov/ct2/show/NCT05069610

Aug 9, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next